Catherine (Cate) Hankins
A community medicine specialist, Professor Hankins’ current scientific interests include implementation science, novel biomedical HIV prevention, participatory research conduct, and scientific knowledge translation and communication. She has been principal investigator of ‘The Canadian Women’s HIV Study’, studies involving prisoners and people who inject drugs, evaluation studies, and population-based epidemiological studies. Chief Scientific Adviser to UNAIDS in Geneva from 2002 for a decade, she led the scientific knowledge translation team focused on ensuring ethical and participatory HIV prevention trial conduct, convening mathematical modelling teams, and supporting country implementation of proven biomedical HIV prevention modalities. She led the development of Good Participatory Practice Guidelines for trials of Emerging Pathogens for the World Health Organization in 2016. She chairs the Scientific Advisory Committee of the European and Developing Countries Clinical Trials Partnership and the Scientific Advisory Group of the US National Institutes of Health HIV Prevention Trials Network. She is a trustee of the HIV Research Trust and a member of the International AIDS Society Industry Liaison Forum. She holds the positions of Deputy Director, Science at the Amsterdam Institute for Global Health and Development, University of Amsterdam, the Netherlands; and Honorary Professor, London School of Hygiene and Tropical Medicine, England. Keenly interested in scientific capacity development and advancing women in global health and science, Professor Hankins is the Scientific Chair of the annual African INTEREST conferences on HIV treatment, pathogenesis, and prevention research in resource-limited settings (2015 Harare, 2016 Yaoundé, 2017 Lilongwe, 2018 Kigali, 2019 Accra) and Co-Chair of the Eastern Europe and Central Asia INTERACT Workshop. She was named to the Order of Canada in 2013.